Grafalon 20mg Injection

Grafalon 20mg Injection contains the active component thymoglobuline. It belongs to a group of medicines called immunosuppressants (anti-rejection medicines). These medicines help prevent rejection of transplanted organs and can also be used to treat other unwanted immune reactions. It is also used in the treatment of moderate to severe aplastic anaemia (bone marrow failure) in patients unsuitable for bone marrow transplantation. Thymoglobuline is produced by injecting human thymus cells into rabbits. It is used especially in patients who have undergone kidney or heart transplant procedures to prevent rejection of the transplanted organ. Additionally, it is employed in treating kidney transplant rejection in patients who do not respond to corticosteroid treatment. Grafalon 20mg Injection is not recommended if you are allergic to thymoglobuline, rabbits, or any of the other ingredients. It is not advised if you have a severe infection, as Grafalon 20mg Injection decreases your body's ability to fight infections. Inform your doctor if you have any blood disorder, fever, or infection before this treatment. Do not receive vaccination during or soon after treatment with this medication without discussing it with your doctor. Before starting treatment, provide a detailed account of your medical history and current medications.

Uses of Grafalon 20mg Injection Kidney and heart transplantation Aplastic anemia

Grafalon 20mg Injection (ATI) contains antibodies that bind to specific immune cells involved in organ rejection or unwanted immune reactions. By targeting these cells, ATI suppresses the immune response, aiding in the acceptance of transplanted organs and treating conditions like aplastic anaemia. It achieves this by depleting circulating lymphocytes, particularly T lymphocytes, through various mechanisms such as complement-dependent lysis and activation-induced apoptosis. Additionally, ATI may induce T lymphocyte anergy, further contributing to immunosuppression.

Grafalon 20mg Injection will be given to you by your healthcare provider in a hospital. It is injected directly into a vein (intravenous infusion) through a plastic tube (catheter). Your healthcare provider determines the dose, duration, and frequency based on your age, body weight, and severity of your condition.

Side effects are unwanted symptoms that occur due to medicines. Even though all drugs cause side effects, not everyone gets them. Serious A raised, itchy rash Difficulty in breathing Stomach pain Swelling of the face, tongue or throat Common Low white blood cell count; low platelet count Fever Infection Low count of red blood cells (anaemia)

Close infection surveillance is essential due to the increased risk associated with immunosuppression. Regular monitoring of liver function, kidney function, and blood counts is advised to detect any potential hepatotoxicity, drug-induced liver injury, renal dysfunction, or blood disorders. Infusion-related reactions should be anticipated and managed appropriately. Infusion-related side effects ( Difficulty breathing, wheezing or coughing, Feeling or being sick, Dizzy or feeling faint, Tiredness, Joint pain, Headache, Bleeding or bruising more easily than normal, Irregular or fast heartbeat. Symptoms of infection such as fever, chills, sore throat, mouth ulcers Pregnant and breastfeeding women should consult a doctor before taking it. Pediatric and geriatric patients require special consideration. Psychological effects should be monitored, and close consultation with healthcare professionals is necessary to ensure safe and effective use of it. Open communication and collaboration with your healthcare team are key to ensuring the safest and most effective medication use.